ObjectivesThe purpose of this study was to evaluate the effect of decalcification and existence of stent at the aortic annulus on mitral annular motion after surgery.MethodsPatients receiving Inspiris (Edwards, CA, USA, n = 117), Intuity (Edwards, n = 36), Perceval (Corcym, London, UK, n = 36), Evolut (Medtronics, MN, USA, n = 81) and Sapien 3 (Edwards, n = 250) were included in the study. Mitral annular motion was evaluated by E', using tissue doppler imaging.ResultsAfter surgery, a significant increase in E' was observed in patients receiving Inspiris (Before: 4.2 +/- 1.21 cm/s vs. Discharge: 5.0 +/- 1.23 cm/s, p < 0.001). Mid-term echocardiogram performed at 11.8 +/- 2.2 months after the surgery, showed a significant increase in E' in patients receiving Inspiris (Before: 4.2 +/- 1.21 cm/s vs. Mid-term: 5.2 +/- 1.20 cm/s, p < 0.001) and Perceval (Before: 3.9 +/- 1.34 cm/s vs. Mid-term: 4.5 +/- 1.24 cm/s, p = 0.008). Univariable analysis showed a higher increase in E' in patients with decalcified annulus compared to those without decalcified annulus (Decalcification: 0.15 +/- 1.321 cm/s vs. No Decalcification: 0.66 +/- 1.420 cm/s, p < 0.001). Multivariable analysis showed that balloon-expandable stent (beta = - 0.6960, p < 0.001) and self-expanding stent (r = - 0.3592, p = 0.042) were independent limiting factors for an increase in E' at discharge. However, balloon-expandable stent (beta = - 0.8382, p < 0.001), and not self-expanding stent (beta = - 0.3682, p = 0.089), was a remaining independent factor associated with E' at mid-term follow-up.ConclusionsDecalcification was associated with improvement in E' after surgery. Balloon-expandable stent was an independent limiting factor for improvement in E' up to 1 year after the surgery, while self-expanding stent was not a significant factor after 1 year.